Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vismodegib in Various Histologic Subtypes of BCC
NCT01700049Phase 2Completed
- Sponsor
- Mayo Clinic
- Start
- Jan 2013
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vismodegib in basal cell carcinoma (BCC), sponsored by Mayo Clinic. Started Jan 2013; status: completed.
02
Drugs
vismodegib
03
Conditions
basal cell carcinoma (BCC)
Beyond the preview
Go deeper on NCT01700049.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01700049.